Efficacy and safety of the intensive dose of rosuvastatin 40 mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.